|
|
 |
|
Viewing report
|
|
|
|
Endovascular Surgical Intervention - Technology Market Penetration Analysis (Technical Insights)
Frost & Sullivan, March 2011, Pages: 77
This Frost & Sullivan research service titled Endovascular Surgical Intervention--Technology Market Penetration Analysis identifies the emerging developments in the field of endovascular surgery and devices on a global scale. This research covers a snapshot of the global corporate and academic initiatives, a Porter’s five forces analysis of the competitive behavior in the industry, strategic initiatives needed, and a technology adoption cycle from the developer’s perspective.
Technology Overview
Development of Novel Devices Trigger a Spate of New Techniques in Endovascular Surgery
The recent introduction of intravascular balloons, stents, and coils have popularized new therapies as alternatives to traditional surgeries such as coronary artery bypass surgery (CABG), carotid endarterectomy, and aneurysm clipping. The impact of stent technology is greater in constantly changing markets such as that of vascular devices, because the rapid discovery of treatments for vascular diseases demands speedy development of new device technology. Further, this constant availability of innovative products in the market has helped to drive back the trend of price erosion and aided market expansion. Continuous inventions have facilitated and promoted endovascular surgery techniques, which are currently being tested for their long-term outcomes and complications. “Several clinical trials are underway, including carotid revascularization endarterectomy versus stent trial (CREST), and international subarachnoid aneurysm trial (ISAT), to assess the long-term effects of the procedures,” says the analyst of this research. “The most common and advanced form of endovascular surgery is an endovascular aneurysm repair (EVAR).” There are more than 2,500 active endovascular surgeons worldwide, and they comprise the primary market for endovascular surgical interventional devices. Apart from the spate of product innovations, the advancement of the Japanese market has ensured continued double-digit growth in recent years.
Endovascular surgical techniques are expected to find considerable application in abdominal aortic aneurysm (AAA), with approximately 4.5 million people estimated to be suffering from it in the developed world. Of these cases, the United States alone accounts for 1.5 million, and each year, the country diagnoses 600,000 new cases. Endovascular repair has also become a widely accepted treatment for aortic aneurysms, with penetration rates reaching 80 percent in the best centers; however, overall penetration rates in the developed world are still below 30 percent. One effective way to increase the penetration rates of vascular therapy is using informative Web portals to educate patients about the various diagnostic and therapeutic options available to them.
Endovascular Surgery’s Overwhelming Benefits Help it Steal the March over Traditional Surgery despite the Shortcomings of Stents
The importance of greater patient awareness becomes evident when despite increased patient screening for aneurysms, the lack of understanding of AAAs often results in late detections. Even if an aneurysm is identified, due to the tortuosity of the infrarenal necks, close to 60 per cent of the female patients and 30 per cent of the male patients have anatomical features unsuited to an AAA stent graft. “Owing to the risks of endoleaks and migration, most stent grafts are only applicable for patients with an aneurysm developing in certain locations of the abdominal aorta; in other cases, open cavity bypass surgeries are still the preferred method of treatment,” notes the analyst. “Moreover, due to the different sizes of the main and descending legs of the aorta, some patients might not have an anatomy that permits the use of devices that are currently available.” For patients who can be treated using graft techniques, the chances of morbidity are 11 per cent less than in open endovascular surgeries.
As conventional management of clinically significant aortic aneurysm consists of surgical excision, it results in a high peri-operative mortality rate. This has led to the emergence of endovascular prosthesis as a minimally invasive, catheter-based alternative to open surgical excision. These minimally invasive devices, in the form of endovascular stent grafts, are deployed across the aneurysm in a way that it is effectively excluded from the circulation, with subsequent restoration of normal blood flow. Post-operative recovery in the intensive care unit is rarely required after the insertion of endovascular stents, as the grafts are characterized by reduced blood transfusion requirements and hospital stays. Further, patients return to pre-intervention levels of activity more rapidly post usage of endovascular stent grafts for AAA repair.
Application Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Stent-assisted carotid angioplasty
- Stent implantation in peripheral and arterial diseases (PAD) treatment
- Endovascular stent grafts
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
